Education
About Us
Working with TipRanks
Follow Us
Raffles Medical Group Ltd (SG:BSL)
SGX:BSL
RESEARCH TOOLSreports
Total Valuation
Raffles Medical Group has a market cap or net worth of $1.90B. The enterprise value is S$1.34B.
Market Cap$1.90B
Enterprise ValueS$1.34B
Share Statistics
Raffles Medical Group has 1,884,544,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,884,544,900
Owned by Insiders58.20%
Owned by Institutions0.04%
Financial Efficiency
Raffles Medical Group’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee251.44K
Profits Per Employee20.84K
Employee Count2,989
Asset Turnover0.49
Inventory Turnover24.66
Valuation Ratios
The current PE Ratio of Raffles Medical Group is 25.37. Raffles Medical Group’s PEG ratio is -0.82.
PE Ratio25.37
PS Ratio3.34
PB Ratio1.50
Price to Fair Value1.50
Price to FCF24.16
Price to Operating Cash Flow18.30
PEG Ratio-0.82
Income Statement
In the last 12 months, Raffles Medical Group had revenue of 751.56M and earned 62.24M in profits. Earnings per share was 0.03.
Revenue751.56M
Gross Profit486.14M
Operating Income82.49M
Pretax Income86.96M
Net Income62.24M
EBITDA135.83M
Earnings Per Share (EPS)0.03
Cash Flow
In the last 12 months, operating cash flow was 97.19M and capital expenditures -22.73M, giving a free cash flow of 74.46M billion.
Operating Cash Flow97.19M
Free Cash Flow74.46M
Free Cash Flow per Share0.04
Dividends & Yields
Raffles Medical Group pays an annual dividend of S$0.025, resulting in a dividend yield of 2.31%
Dividend Per ShareS$0.025
Dividend Yield2.31%
Payout Ratio72.73%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change0.40%
50-Day Moving Average0.95
200-Day Moving Average0.91
Relative Strength Index (RSI)61.83
Average Volume (3m)3.33M
Important Dates
Raffles Medical Group upcoming earnings date is Jul 28, 2025, TBA Not Confirmed.
Last Earnings DateFeb 23, 2025
Next Earnings DateJul 28, 2025
Ex-Dividend DateMay 13, 2025
Financial Position
Raffles Medical Group as a current ratio of 1.35, with Debt / Equity ratio of 8.40%
Current Ratio1.35
Quick Ratio1.32
Debt to Market Cap0.04
Net Debt to EBITDA―
Interest Coverage Ratio14.27
Taxes
In the past 12 months, Raffles Medical Group has paid 24.68M in taxes.
Income Tax24.68M
Effective Tax Rate0.28
Enterprise Valuation
Raffles Medical Group EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Raffles Medical Group has $316.32M in cash and marketable securities with S$114.65M in debt, giving a net cash position of -$207.03M billion.
Cash & Marketable Securities$316.32M
Total DebtS$114.65M
Net Cash-$207.03M
Net Cash Per Share-$0.11
Tangible Book Value Per Share$0.57
Margins
Gross margin is 51.72%, with operating margin of 10.98%, and net profit margin of 8.28%.
Gross Margin51.72%
Operating Margin10.98%
Pretax Margin11.57%
Net Profit Margin8.28%
EBITDA Margin18.07%
EBIT Margin12.34%
Analyst Forecast
The average price target for Raffles Medical Group is $1.08, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$1.08
Price Target Upside6.45% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast6.30%
EPS Growth Forecast-30.93%